Financhill
Back

Intra-Cellular Therapies Stock Price Chart

Unlock the power of "two-minute trades"

Learn how today!
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Free Stock Analysis Report: Get a clear concise Stock Rating

Analyze Any Stock Free
  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

Intra-Cellular Therapies Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

Intra-Cellular Therapies Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Intra-Cellular Therapies Stock

Is Intra-Cellular Therapies Stock a Buy?

ITCI Technical Analysis vs Fundamental Analysis

Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy or a Sell?

Intra-Cellular Therapies Stock Info

Market Cap:
10.1B
Price in USD:
94.87
Share Volume:
4.1M

Intra-Cellular Therapies 52-Week Range

52-Week High:
98.40
52-Week Low:
62.78
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Intra-Cellular Therapies Share Price Forecast

Is Intra-Cellular Therapies Stock a Buy?

Fundamental Analysis of Intra-Cellular Therapies

Is Intra-Cellular Therapies a good investment?

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

Technical Analysis of Intra-Cellular Therapies

Should I short Intra-Cellular Therapies stock?

* Intra-Cellular Therapies stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.